Tolerion, Inc.

Tolerion has a novel, patented drug in Phase 2 that has potential for being the first disease modifying therapy in type 1 diabetes.

  • Stage Product In Development
  • Industry Biotechnology
  • Location Portola Valley, CA, USA
  • Currency USD
  • Founded June 2012
  • Employees 0
  • Website tolerioninc.com

Only investors on Gust who have been granted access can view this content.

Interested in this startup? Sign In or Sign Up to request more information.

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free